Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

A Multi-Center Quality Improvement Intervention to Reduce the Inappropriate Use of Aspirin Among Patients Anticoagulated with Warfarin for Atrial Fibrillation or Venous Thromboembolism

Jordan K Schaefer, MD, Josh Errickson, PhD, Xiaokui Gu, MA, Tina Alexandris-Souphis, RN, Mona A Ali, PharmD, Brian Haymart, RN, MS, Scott Kaatz, DO, MSc, Eva Kline-Rogers, RN, MS, Jay H Kozlowski, MD, Gregory D Krol, Suman L Sood, MD, James B Froehlich, MD MPH, Geoffrey D Barnes, MD MSc

Blood (2019) 134 (Supplement_1): 788.

https://doi.org/10.1182/blood-2019-123067

Published: 2019

Journal Articles

Impact of Adding Aspirin to Direct Oral Anticoagulant Therapy without an Apparent Indication

Jordan K Schaefer, MD, Yun Li, PhD, Xiaowen Kong, MA, Tina Alexandris-Souphis, RN, Mona A Ali, PharmD, Brian Haymart, RN, MS, Scott Kaatz, DO, MSc, Eva Kline-Rogers, RN, MS, Jay H Kozlowski, MD, Gregory D Krol, Sahana R Shankar, Suman L Sood, MD, James B Froehlich, MD MPH, Geoffrey D Barnes, MD MSc

Blood (2019) 134 (Supplement_1): 787.

https://doi.org/10.1182/blood-2019-122526

Published: 2019

Journal Articles

The Impact of Adding Aspirin to Warfarin without an Apparent Indication: An Exploration of Patients Anticoagulated for Atrial Fibrillation or Venous Thromboembolic Disease

Jordan K. Schaefer, MD, Nicole M. Souphis, Suman L. Sood, MD MSCE, Brian Haymart, RN, MS, Xiaokui Gu, MA, Eva Kline-Rogers, RN, MS, Steven L. Almany, MD, Jay H. Kozlowski, MD, Gregory D. Krol, MD, Scott Kaatz, DO, MSc, James B. Froehlich, MD MPH, Geoffrey D. Barnes, MD MSc

Blood (2017) 130 (Supplement 1): 220.

https://doi.org/10.1182/blood.V130.Suppl_1.220.220

Published: 2017

Journal Articles

A Comparison of Socioeconomic Factors in Patients Continuing Warfarin Versus Those Transitioning to Direct Oral Anticoagulants (DOACs) for Venous Thromboembolic Disease or Atrial Fibrillation

Jordan K. Schaefer, MD, Suman L. Sood, MD MSCE, Brian Haymart, RN, MS, Xiaokui Gu, MA, Eva Kline-Rogers, RN, MS, Steven L. Almany, MD, Jay H. Kozlowski, MD, Gregory D. Krol, MD, Scott Kaatz, DO, MSc, James B. Froehlich, MD MPH, Geoffrey D. Barnes, MD MSc

Blood (2016) 128 (22): 1179.

https://doi.org/10.1182/blood.V128.22.1179.1179

Published: 2016

Journal Articles

E-Selectin Antagonist GMI-1271 Shows a Favorable Safety, PK and Bleeding Profile in Phase I Studies of Healthy Volunteers

Dana E. Angelini, MD, Sumana Devata, MD, Angela E. Hawley, Susan A. Blackburn, RN, MBA, Satwinder Grewal, Martina V Hemmer, MA, Henry Flanner, MS, William Kramer, PhD, William E Parker, Yu-Ling Li, MS, MD, Daniel Durant Myers, DVM, MPH, James B. Froehlich, MD MPH, John L Magnani, PhD, Helen M. Thackray, MD, Thomas W. Wakefield, MD, Suman L. Sood, MD MSCE

Blood (2016) 128 (22): 3826.

https://doi.org/10.1182/blood.V128.22.3826.3826

Published: 2016

Journal Articles

Venous Thromboembolism Prophylaxis Practices in Acutely Ill Medical Patients with Heart Failure (NYHA Class III or IV): Findings from IMPROVE.

Ricardo Pavanello, MD, James B. Froehlich, MD, Victor Tapson, MD, Jean-Francois Bergmann, MD, Mashio Nakamura, MD, Geno Merli, MD, Mario Pini, MD, Franco Piovella, MD, Frederick A. Spencer, MD, Gordon FitzGerald, Frederick A. Anderson, Jr., PhD, For the IMPROVE Investigators11

Blood (2005) 106 (11): 1869.

https://doi.org/10.1182/blood.V106.11.1869.1869

Published: 2005

Journal Articles

Factors at Admission That Are Predictive of Increased In-Hospital Bleeding in Acutely Ill Medical Patients: Findings from the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE).

Hervé Decousus, MD, Rainer B. Zotz, MD, Victor F. Tapson, MD, Beng H. Chong, MD, PhD, James B. Froehlich, MD, Ricardo Pavanello, MD, Alex C. Spyropoulos, MD, Manuel Monreal, MD, Gordon FitzGerald, Frederick A. Anderson, Jr., PhD, for the IMPROVE Investigators

Blood (2005) 106 (11): 264.

https://doi.org/10.1182/blood.V106.11.264.264

Published: 2005

NARROW

A Multi-Center Quality Improvement Intervention to Reduce the Inappropriate Use of Aspirin Among Patients Anticoagulated with Warfarin for Atrial Fibrillation or Venous Thromboembolism

Impact of Adding Aspirin to Direct Oral Anticoagulant Therapy without an Apparent Indication

The Impact of Adding Aspirin to Warfarin without an Apparent Indication: An Exploration of Patients Anticoagulated for Atrial Fibrillation or Venous Thromboembolic Disease

A Comparison of Socioeconomic Factors in Patients Continuing Warfarin Versus Those Transitioning to Direct Oral Anticoagulants (DOACs) for Venous Thromboembolic Disease or Atrial Fibrillation

E-Selectin Antagonist GMI-1271 Shows a Favorable Safety, PK and Bleeding Profile in Phase I Studies of Healthy Volunteers

Venous Thromboembolism Prophylaxis Practices in Acutely Ill Medical Patients with Heart Failure (NYHA Class III or IV): Findings from IMPROVE.

Factors at Admission That Are Predictive of Increased In-Hospital Bleeding in Acutely Ill Medical Patients: Findings from the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE).

Email alerts

ASH Publications

American Society of Hematology

A Multi-Center Quality Improvement Intervention to Reduce the Inappropriate Use of Aspirin Among Patients Anticoagulated with Warfarin for Atrial Fibrillation or Venous Thromboembolism

Impact of Adding Aspirin to Direct Oral Anticoagulant Therapy without an Apparent Indication

The Impact of Adding Aspirin to Warfarin without an Apparent Indication: An Exploration of Patients Anticoagulated for Atrial Fibrillation or Venous Thromboembolic Disease

A Comparison of Socioeconomic Factors in Patients Continuing Warfarin Versus Those Transitioning to Direct Oral Anticoagulants (DOACs) for Venous Thromboembolic Disease or Atrial Fibrillation

E-Selectin Antagonist GMI-1271 Shows a Favorable Safety, PK and Bleeding Profile in Phase I Studies of Healthy Volunteers

Venous Thromboembolism Prophylaxis Practices in Acutely Ill Medical Patients with Heart Failure (NYHA Class III or IV): Findings from IMPROVE.

Factors at Admission That Are Predictive of Increased In-Hospital Bleeding in Acutely Ill Medical Patients: Findings from the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only